Premium
Development of human ABO blood group A antigen on Escherichia coli Y1089 and Y1090
Author(s) -
YANG NAN,
BOETTCHER BARRY
Publication year - 1992
Publication title -
immunology and cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.999
H-Index - 104
eISSN - 1440-1711
pISSN - 0818-9641
DOI - 10.1038/icb.1992.54
Subject(s) - antigen , polyclonal antibodies , abo blood group system , epitope , escherichia coli , monoclonal antibody , agglutination (biology) , antibody , h antigen , biology , microbiology and biotechnology , transferase , serotype , enzyme , chemistry , biochemistry , immunology , gene
Summary Studies by other workers have shown that some strains of Escherichia coli have surface antigens analogous to the human blood group ABH antigens, and that these are carbohydrates associated with membrane lipopolysaccharides. This study has demonstrated that E. coli strains Y1089 and Y1090 possess the H antigen, which can be converted to the A antigen by incubation with A‐transferase (N‐acetyl‐galactosaminyl transferase) and A‐sugar (UDP‐N‐acetyl‐galactosamine). Such cells will then form mixed agglutinates with human A red cells and human polyclonal (but not mouse monoclonal) anti‐A antibodies. E. coli Y1089 and Y1090 have endogenous enzymes that use the A‐sugar (in the absence of A‐ transferase) to produce a variant A antigen. Cells expressing this variant antigen adsorb anti‐A antibodies but do not participate in mixed agglutination with human group A red cells. It is estimated that E. coli Y1089 and Y1090 possess approximately 5000 H epitopes per cell that can be converted to A epitopes.